Montelukast

• Background:

  Montelukast is a cysteinyl leukotriene receptor 1 (CysLT1) antagonist. It blocks pentylenetetrazole-induced seizures, blood brain barrier disruption and leukocyte migration in mice.

• Description:

  Leukotriene CysLT1 antagonist

• Product Name Alternative:

  1-[[[ (1R) -1-[3- (1E) -2- (7-chloro-2-quinolinyl) ethenyl]phenyl]-3-[2- (1-hydroxy-1-methylethyl) phenyl]propyl]thio]-methyl]-cyclopropaneacetic acid, monosodium salt, Montelukast sodium, Montelukast monosodium salt, MK-0476, MK-476, KS-1087

• UNSPSC:

  41116105

• Type:

  Antagonist

• Source:

  Synthetic

• Field of Research:

  Immunology | Innate Immunity | Macrophage

• Purity:

  >98% (HPLC) ; NMR (Conforms)

• Weight:

  0.25

• Format:

  Powder

• Solubility:

  Soluble in DMSO (50 mg/ml), or water (30 mg/ml), or ethanol (60 mg/ml)

• Molecular Formula:

  C35H35ClNO3S • Na

• Molecular Weight:

  608.2

• Precautions:

  Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

• CAS Number:

  151767-02-1